Evaluation of the effect of Propolis on insulin resistance in patients with type 2 diabetes.
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000008479
- Lead Sponsor
- Kyoto Prefectural University of Medicine, Graduate School of Medical Science
- Brief Summary
The significant difference of HOMA-IR, HbA1c, blood sugar and insulin level were not observed in a propolis group and a placebo group. The significant decrease of triglyceride was obserbed in the propolis group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who did not agree with joining this study. 2)Patients with severe renal dysfunction or severe hepatic dysfunction. 3)Pregnant women, women who may be pregnant, and breast-feeding women. 4)Patients treated with insulin. 5)Patients who are ineligible for some other reason judged by attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in HOMA-IR after 8 weeks of treatment
- Secondary Outcome Measures
Name Time Method Changes in FPG,HbA1c,total cholesterol, HDL,LDL,triglyceride,serum insulin,remnant like particle cholesterol(RLP-C),HMW-adiponectin,TNF-alpha,high sensitive CRP,IL-6 and urine pH after 8 weeks of treatment.